Stoke Therapeutics
STOK
STOK
197 hedge funds and large institutions have $2.31B invested in Stoke Therapeutics in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.94% more ownership
Funds ownership: 117.28% → 120.21% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
57% less call options, than puts
Call options by funds: $3.7M | Put options by funds: $8.68M
Holders
197
Holding in Top 10
4
Calls
$3.7M
Puts
$8.68M
Top Buyers
| 1 | +$77.4M | |
| 2 | +$51.2M | |
| 3 | +$21.4M | |
| 4 |
Millennium Management
New York
|
+$15.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$21M | |
| 3 | -$10.5M | |
| 4 |
Goldman Sachs
New York
|
-$10.2M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$8.26M |
